Antibody Production Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Antibody Production Market
1.1. Definition and Scope
1.1.1. Definition of Antibody Production
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Antibody Production Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Antibody Production Market By Product
1.2.3. Antibody Production Market By Process
1.2.4. Antibody Production Market By Type
1.2.5. Antibody Production Market By End-use
1.2.6. Antibody Production Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Antibody Production Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Antibody Production Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Antibody Production Market By Product
5.1. Introduction
5.2. Antibody Production Revenue By Product
5.2.1. Antibody Production Revenue (USD Billion) and Forecast, By Product, 2020-2032
5.2.2. Instruments
5.2.2.1. InstrumentsMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Bioreactors
5.2.2.2.1. Bioreactors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Filtration systems
5.2.2.3.1. Filtration Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.4. Chromatography Systems
5.2.2.4.1. Chromatography Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Consumables
5.2.3.1. Consumables Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.2. Media
5.2.3.2.1. Media Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.3. Filtration Consumables and Accessories
5.2.3.3.1. Filtration Consumables and Accessories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.4. Chromatography Resins and Columns
5.2.3.4.1. Chromatography Resins and Columns Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.5. Buffers and Reagents
5.2.3.5.1. Buffers and Reagents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.6. Others
5.2.3.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Software
5.2.4.1. Software Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Antibody Production Market By Process
6.1. Introduction
6.2. Antibody Production Revenue By Process
6.2.1. Antibody Production Revenue (USD Billion) and Forecast, By Process, 2020-2032
6.2.2. Downstream Processing
6.2.2.1. Downstream Processing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Upstream Processing
6.2.3.1. Upstream Processing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Antibody Production Market By Type
7.1. Introduction
7.2. Antibody Production Revenue By Type
7.2.1. Antibody Production Revenue (USD Billion) and Forecast, By Type, 2020-2032
7.2.2. Polyclonal Antibody
7.2.2.1. Polyclonal Antibody Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Monoclonal Antibody
7.2.3.1. Monoclonal Antibody Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Antibody Production Market By End-use
8.1. Introduction
8.2. Antibody Production Revenue By End-use
8.2.1. Antibody Production Revenue (USD Billion) and Forecast, By End-use, 2020-2032
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.2.1. Pharmaceutical and Biotechnology Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. CROs and CDMOs
8.2.3.1. CROs and CDMOs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Research Laboratories
8.2.4.1. Research Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Antibody Production Market By Country
9.1. North America Antibody Production Market Overview
9.2. U.S.
9.2.1. U.S. Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. U.S. Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
9.2.3. U.S. Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.4. U.S. Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.3. Canada
9.3.1. Canada Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Canada Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
9.3.3. Canada Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.4. Canada Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Antibody Production Market By Country
10.1. Europe Antibody Production Market Overview
10.2. U.K.
10.2.1. U.K. Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. U.K. Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
10.2.3. U.K. Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.4. U.K. Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.3. Germany
10.3.1. Germany Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Germany Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
10.3.3. Germany Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.4. Germany Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.4. France
10.4.1. France Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. France Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
10.4.3. France Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.4. France Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.5. Spain
10.5.1. Spain Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.2. Spain Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
10.5.3. Spain Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
10.5.4. Spain Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.2. Rest of Europe Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
10.6.3. Rest of Europe Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
10.6.4. Rest of Europe Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Antibody Production Market By Country
11.1. Asia Pacific Antibody Production Market Overview
11.2. China
11.2.1. China Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. China Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
11.2.3. China Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.4. China Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.3. Japan
11.3.1. Japan Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Japan Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
11.3.3. Japan Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.4. Japan Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.4. India
11.4.1. India Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. India Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
11.4.3. India Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.4. India Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.5. Australia
11.5.1. Australia Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5.2. Australia Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
11.5.3. Australia Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
11.5.4. Australia Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.6. South Korea
11.6.1. South Korea Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
11.6.2. South Korea Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
11.6.3. South Korea Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
11.6.4. South Korea Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
11.7.2. Rest of Asia-Pacific Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
11.7.3. Rest of Asia-Pacific Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
11.7.4. Rest of Asia-Pacific Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Antibody Production Market By Country
12.1. Latin America Antibody Production Market Overview
12.2. Brazil
12.2.1. Brazil Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. Brazil Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
12.2.3. Brazil Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
12.2.4. Brazil Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.3. Mexico
12.3.1. Mexico Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. Mexico Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
12.3.3. Mexico Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
12.3.4. Mexico Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. Rest of Latin America Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
12.4.3. Rest of Latin America Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
12.4.4. Rest of Latin America Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Antibody Production Market By Country
13.1. Middle East & Africa Antibody Production Market Overview
13.2. GCC
13.2.1. GCC Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
13.2.2. GCC Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
13.2.3. GCC Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
13.2.4. GCC Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.3. South Africa
13.3.1. South Africa Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
13.3.2. South Africa Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
13.3.3. South Africa Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
13.3.4. South Africa Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Antibody Production Revenue (USD Billion) and Forecast By Product, 2020-2032
13.4.2. Rest of Middle East & Africa Antibody Production Revenue (USD Billion) and Forecast By Process, 2020-2032
13.4.3. Rest of Middle East & Africa Antibody Production Revenue (USD Billion) and Forecast By Type, 2020-2032
13.4.4. Rest of Middle East & Africa Antibody Production Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Antibody Production Market
14.1. Antibody Production Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Antibody Production Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Thermo Fisher Scientific
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Thermo Fisher Scientific 2022 Antibody Production Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Merck KGaA
15.3. Abcam
15.4. Bio-Rad Laboratories
15.5. GenScript
15.6. Lonza Group
15.7. Cell Signaling Technology
15.8. BioLegend
15.9. Agilent Technologies
15.10. Novus Biologicals
15.11. Proteintech Group
15.12. Rockland Immunochemicals
Frequently Asked Questions
What was the market size of the global antibody production in 2022?
The market size of antibody production was USD 17.3 Billion in 2022.
What is the CAGR of the global antibody production market from 2023 to 2032?
The CAGR of antibody production is 13.2% during the analysis period of 2023 to 2032.
Which are the key players in the antibody production market?
The key players operating in the global market are including Thermo Fisher Scientific, Merck KGaA, Abcam, Bio-Rad Laboratories, GenScript, Lonza Group, Cell Signaling Technology, BioLegend, Agilent Technologies, Novus Biologicals, Proteintech Group, and Rockland Immunochemicals.
Which region dominated the global antibody production market share?
North America held the dominating position in antibody production industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of antibody production during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global antibody production industry?
The current trends and dynamics in the antibody production industry include rise in demand for targeted therapies and precision medicine, increased investment in biopharmaceutical research and development, and growing prevalence of chronic diseases and infectious agents.
Which product held the maximum share in 2022?
The consumables product held the maximum share of the antibody production industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
